Loading clinical trials...
Loading clinical trials...
Studying Cognition in SPG4 Compared to Healthy Controls
Comparing the cognitive levels of patients with SPG4 mutations to healthy controls.
Comparing the cognitive levels of patients with SPG4 mutations to healthy controls by using the CANTAB® and MoCA.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
Yes
University Hospital Tübingen, Center for Neurology
Tübingen, Germany
Start Date
May 10, 2017
Primary Completion Date
December 24, 2017
Completion Date
December 24, 2017
Last Updated
August 28, 2020
50
ACTUAL participants
CANTAB
DIAGNOSTIC_TEST
MOCA
DIAGNOSTIC_TEST
Lead Sponsor
University Hospital Tuebingen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04123314